バイオシミラー薬品の世界市場:販売動向2018

【英語タイトル】Global Biosimilar Drug Sales Market Report 2018

QYResearchが出版した調査資料(QYR80702440)・商品コード:QYR80702440
・発行会社(調査会社):QYResearch
・発行日:2018年10月
・ページ数:103
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥856,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、バイオシミラー薬品の世界市場について調査・分析し、バイオシミラー薬品のメーカー別販売量、市場シェア分析、種類別販売分析(注射液、錠剤、その他)、用途別販売分析(強直性脊椎炎、腫瘍、関節リウマチ、循環器系疾患、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、バイオシミラー薬品産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・バイオシミラー薬品市場概要
・バイオシミラー薬品のメーカー別販売量・メーカー別シェア
・バイオシミラー薬品の世界市場:種類別販売量(注射液、錠剤、その他)
・バイオシミラー薬品の世界市場:用途別販売量(強直性脊椎炎、腫瘍、関節リウマチ、循環器系疾患、その他)
・バイオシミラー薬品の世界市場:地域別販売量・市場シェア
・バイオシミラー薬品の米国市場規模
・バイオシミラー薬品の中国市場規模
・バイオシミラー薬品の欧州市場規模
・バイオシミラー薬品の日本市場規模
・バイオシミラー薬品の東南アジア市場規模
・バイオシミラー薬品のインド市場規模
・バイオシミラー薬品のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・バイオシミラー薬品のコスト分析・価格動向
・バイオシミラー薬品の産業チェーン(サプライチェーン分析)
・バイオシミラー薬品のマーケティング戦略・販売チャネル、流通業者
・バイオシミラー薬品市場への影響要因分析
・バイオシミラー薬品の世界市場予測
・バイオシミラー薬品の米国市場予測
・バイオシミラー薬品の中国市場予測
・バイオシミラー薬品の欧州市場予測
・バイオシミラー薬品の日本市場予測
・バイオシミラー薬品の東南アジア市場予測
・バイオシミラー薬品のインド市場予測
・バイオシミラー薬品の種類別世界市場予測(注射液、錠剤、その他)
・バイオシミラー薬品の用途別世界市場予測(強直性脊椎炎、腫瘍、関節リウマチ、循環器系疾患、その他)
...
【レポートの概要】

This report studies the global Biosimilar Drug market status and forecast, categorizes the global Biosimilar Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we’re using our more than 35 years of biologics experience to develop high-quality biosimilars.

First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.

Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.

Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.

Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.

At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.

The global Biosimilar Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Amgen
Eli Lilly
Novartis
CP Guojian Pharma
Biotech Pharma

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Injection
Tablets
Other Types
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application

The study objectives of this report are:
To analyze and study the global Biosimilar Drug sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Biosimilar Drug players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilar Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Biosimilar Drug Manufacturers
Biosimilar Drug Distributors/Traders/Wholesalers
Biosimilar Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Biosimilar Drug market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Biosimilar Drug Sales Market Report 2018
1 Biosimilar Drug Market Overview
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Classification of Biosimilar Drug by Product Category
1.2.1 Global Biosimilar Drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Biosimilar Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Injection
1.2.4 Tablets
1.2.5 Other Types
1.3 Global Biosimilar Drug Market by Application/End Users
1.3.1 Global Biosimilar Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Ankylosing Spondylitis
1.3.2 Tumor
1.3.3 Rheumatoid Arthrtis
1.3.4 Cardiovascular
1.3.5 Other Application
1.4 Global Biosimilar Drug Market by Region
1.4.1 Global Biosimilar Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Biosimilar Drug Status and Prospect (2013-2025)
1.4.3 Europe Biosimilar Drug Status and Prospect (2013-2025)
1.4.4 China Biosimilar Drug Status and Prospect (2013-2025)
1.4.5 Japan Biosimilar Drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Biosimilar Drug Status and Prospect (2013-2025)
1.4.7 India Biosimilar Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Biosimilar Drug (2013-2025)
1.5.1 Global Biosimilar Drug Sales and Growth Rate (2013-2025)
1.5.2 Global Biosimilar Drug Revenue and Growth Rate (2013-2025)

2 Global Biosimilar Drug Competition by Players/Suppliers, Type and Application
2.1 Global Biosimilar Drug Market Competition by Players/Suppliers
2.1.1 Global Biosimilar Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Biosimilar Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Biosimilar Drug (Volume and Value) by Type
2.2.1 Global Biosimilar Drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Biosimilar Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Biosimilar Drug (Volume and Value) by Region
2.3.1 Global Biosimilar Drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Biosimilar Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Biosimilar Drug (Volume) by Application

3 United States Biosimilar Drug (Volume, Value and Sales Price)
3.1 United States Biosimilar Drug Sales and Value (2013-2018)
3.1.1 United States Biosimilar Drug Sales and Growth Rate (2013-2018)
3.1.2 United States Biosimilar Drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Biosimilar Drug Sales Price Trend (2013-2018)
3.2 United States Biosimilar Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Biosimilar Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Biosimilar Drug Sales Volume and Market Share by Application (2013-2018)

4 Europe Biosimilar Drug (Volume, Value and Sales Price)
4.1 Europe Biosimilar Drug Sales and Value (2013-2018)
4.1.1 Europe Biosimilar Drug Sales and Growth Rate (2013-2018)
4.1.2 Europe Biosimilar Drug Revenue and Growth Rate (2013-2018)
4.1.3 Europe Biosimilar Drug Sales Price Trend (2013-2018)
4.2 Europe Biosimilar Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Biosimilar Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Biosimilar Drug Sales Volume and Market Share by Application (2013-2018)

5 China Biosimilar Drug (Volume, Value and Sales Price)
5.1 China Biosimilar Drug Sales and Value (2013-2018)
5.1.1 China Biosimilar Drug Sales and Growth Rate (2013-2018)
5.1.2 China Biosimilar Drug Revenue and Growth Rate (2013-2018)
5.1.3 China Biosimilar Drug Sales Price Trend (2013-2018)
5.2 China Biosimilar Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Biosimilar Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Biosimilar Drug Sales Volume and Market Share by Application (2013-2018)

6 Japan Biosimilar Drug (Volume, Value and Sales Price)
6.1 Japan Biosimilar Drug Sales and Value (2013-2018)
6.1.1 Japan Biosimilar Drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Biosimilar Drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Biosimilar Drug Sales Price Trend (2013-2018)
6.2 Japan Biosimilar Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Biosimilar Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Biosimilar Drug Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Biosimilar Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Biosimilar Drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Biosimilar Drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Biosimilar Drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Biosimilar Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Biosimilar Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Biosimilar Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Biosimilar Drug Sales Volume and Market Share by Application (2013-2018)

8 India Biosimilar Drug (Volume, Value and Sales Price)
8.1 India Biosimilar Drug Sales and Value (2013-2018)
8.1.1 India Biosimilar Drug Sales and Growth Rate (2013-2018)
8.1.2 India Biosimilar Drug Revenue and Growth Rate (2013-2018)
8.1.3 India Biosimilar Drug Sales Price Trend (2013-2018)
8.2 India Biosimilar Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Biosimilar Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Biosimilar Drug Sales Volume and Market Share by Application (2013-2018)

9 Global Biosimilar Drug Players/Suppliers Profiles and Sales Data
9.1 Amgen
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Biosimilar Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Eli Lilly
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Biosimilar Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Novartis
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Biosimilar Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Novartis Biosimilar Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 CP Guojian Pharma
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Biosimilar Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Biotech Pharma
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Biosimilar Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview

10 Biosimilar Drug Maufacturing Cost Analysis
10.1 Biosimilar Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Biosimilar Drug
10.3 Manufacturing Process Analysis of Biosimilar Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Biosimilar Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Biosimilar Drug Market Forecast (2018-2025)
14.1 Global Biosimilar Drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Biosimilar Drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Biosimilar Drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Biosimilar Drug Price and Trend Forecast (2018-2025)
14.2 Global Biosimilar Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Biosimilar Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Biosimilar Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Biosimilar Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Biosimilar Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Biosimilar Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Biosimilar Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Biosimilar Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Biosimilar Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Biosimilar Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Biosimilar Drug Sales Forecast by Type (2018-2025)
14.3.2 Global Biosimilar Drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Biosimilar Drug Price Forecast by Type (2018-2025)
14.4 Global Biosimilar Drug Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Biosimilar Drug
Figure Global Biosimilar Drug Sales Volume Comparison (K DDD) by Type (2013-2025)
Figure Global Biosimilar Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Injection Product Picture
Figure Tablets Product Picture
Figure Other Types Product Picture
Figure Global Biosimilar Drug Sales Comparison (K DDD) by Application (2013-2025)
Figure Global Sales Market Share of Biosimilar Drug by Application in 2017
Figure Ankylosing Spondylitis Examples
Table Key Downstream Customer in Ankylosing Spondylitis
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Rheumatoid Arthrtis Examples
Table Key Downstream Customer in Rheumatoid Arthrtis
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Other Application Examples
Table Key Downstream Customer in Other Application
Figure Global Biosimilar Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Biosimilar Drug Sales Volume (K DDD) and Growth Rate (2013-2025)
Figure Global Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Biosimilar Drug Sales Volume (K DDD) (2013-2018)
Table Global Biosimilar Drug Sales (K DDD) of Key Players/Suppliers (2013-2018)
Table Global Biosimilar Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Biosimilar Drug Sales Share by Players/Suppliers
Figure 2017 Biosimilar Drug Sales Share by Players/Suppliers
Figure Global Biosimilar Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Biosimilar Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Biosimilar Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Biosimilar Drug Revenue Share by Players
Table 2017 Global Biosimilar Drug Revenue Share by Players
Table Global Biosimilar Drug Sales (K DDD) and Market Share by Type (2013-2018)
Table Global Biosimilar Drug Sales Share (K DDD) by Type (2013-2018)
Figure Sales Market Share of Biosimilar Drug by Type (2013-2018)
Figure Global Biosimilar Drug Sales Growth Rate by Type (2013-2018)
Table Global Biosimilar Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Biosimilar Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Type (2013-2018)
Figure Global Biosimilar Drug Revenue Growth Rate by Type (2013-2018)
Table Global Biosimilar Drug Sales Volume (K DDD) and Market Share by Region (2013-2018)
Table Global Biosimilar Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Biosimilar Drug by Region (2013-2018)
Figure Global Biosimilar Drug Sales Growth Rate by Region in 2017
Table Global Biosimilar Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Biosimilar Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Region (2013-2018)
Figure Global Biosimilar Drug Revenue Growth Rate by Region in 2017
Table Global Biosimilar Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Biosimilar Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Region (2013-2018)
Figure Global Biosimilar Drug Revenue Market Share by Region in 2017
Table Global Biosimilar Drug Sales Volume (K DDD) and Market Share by Application (2013-2018)
Table Global Biosimilar Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Biosimilar Drug by Application (2013-2018)
Figure Global Biosimilar Drug Sales Market Share by Application (2013-2018)
Figure United States Biosimilar Drug Sales (K DDD) and Growth Rate (2013-2018)
Figure United States Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Biosimilar Drug Sales Price (USD/DDD) Trend (2013-2018)
Table United States Biosimilar Drug Sales Volume (K DDD) by Players (2013-2018)
Table United States Biosimilar Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Biosimilar Drug Sales Volume Market Share by Players in 2017
Table United States Biosimilar Drug Sales Volume (K DDD) by Type (2013-2018)
Table United States Biosimilar Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Biosimilar Drug Sales Volume Market Share by Type in 2017
Table United States Biosimilar Drug Sales Volume (K DDD) by Application (2013-2018)
Table United States Biosimilar Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Biosimilar Drug Sales Volume Market Share by Application in 2017
Figure Europe Biosimilar Drug Sales (K DDD) and Growth Rate (2013-2018)
Figure Europe Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Biosimilar Drug Sales Price (USD/DDD) Trend (2013-2018)
Table Europe Biosimilar Drug Sales Volume (K DDD) by Players (2013-2018)
Table Europe Biosimilar Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Biosimilar Drug Sales Volume Market Share by Players in 2017
Table Europe Biosimilar Drug Sales Volume (K DDD) by Type (2013-2018)
Table Europe Biosimilar Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Biosimilar Drug Sales Volume Market Share by Type in 2017
Table Europe Biosimilar Drug Sales Volume (K DDD) by Application (2013-2018)
Table Europe Biosimilar Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Biosimilar Drug Sales Volume Market Share by Application in 2017
Figure China Biosimilar Drug Sales (K DDD) and Growth Rate (2013-2018)
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Biosimilar Drug Sales Price (USD/DDD) Trend (2013-2018)
Table China Biosimilar Drug Sales Volume (K DDD) by Players (2013-2018)
Table China Biosimilar Drug Sales Volume Market Share by Players (2013-2018)
Figure China Biosimilar Drug Sales Volume Market Share by Players in 2017
Table China Biosimilar Drug Sales Volume (K DDD) by Type (2013-2018)
Table China Biosimilar Drug Sales Volume Market Share by Type (2013-2018)
Figure China Biosimilar Drug Sales Volume Market Share by Type in 2017
Table China Biosimilar Drug Sales Volume (K DDD) by Application (2013-2018)
Table China Biosimilar Drug Sales Volume Market Share by Application (2013-2018)
Figure China Biosimilar Drug Sales Volume Market Share by Application in 2017
Figure Japan Biosimilar Drug Sales (K DDD) and Growth Rate (2013-2018)
Figure Japan Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Biosimilar Drug Sales Price (USD/DDD) Trend (2013-2018)
Table Japan Biosimilar Drug Sales Volume (K DDD) by Players (2013-2018)
Table Japan Biosimilar Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Biosimilar Drug Sales Volume Market Share by Players in 2017
Table Japan Biosimilar Drug Sales Volume (K DDD) by Type (2013-2018)
Table Japan Biosimilar Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Biosimilar Drug Sales Volume Market Share by Type in 2017
Table Japan Biosimilar Drug Sales Volume (K DDD) by Application (2013-2018)
Table Japan Biosimilar Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Biosimilar Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Biosimilar Drug Sales (K DDD) and Growth Rate (2013-2018)
Figure Southeast Asia Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Biosimilar Drug Sales Price (USD/DDD) Trend (2013-2018)
Table Southeast Asia Biosimilar Drug Sales Volume (K DDD) by Players (2013-2018)
Table Southeast Asia Biosimilar Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Biosimilar Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Biosimilar Drug Sales Volume (K DDD) by Type (2013-2018)
Table Southeast Asia Biosimilar Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Biosimilar Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Biosimilar Drug Sales Volume (K DDD) by Application (2013-2018)
Table Southeast Asia Biosimilar Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Biosimilar Drug Sales Volume Market Share by Application in 2017
Figure India Biosimilar Drug Sales (K DDD) and Growth Rate (2013-2018)
Figure India Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Biosimilar Drug Sales Price (USD/DDD) Trend (2013-2018)
Table India Biosimilar Drug Sales Volume (K DDD) by Players (2013-2018)
Table India Biosimilar Drug Sales Volume Market Share by Players (2013-2018)
Figure India Biosimilar Drug Sales Volume Market Share by Players in 2017
Table India Biosimilar Drug Sales Volume (K DDD) by Type (2013-2018)
Table India Biosimilar Drug Sales Volume Market Share by Type (2013-2018)
Figure India Biosimilar Drug Sales Volume Market Share by Type in 2017
Table India Biosimilar Drug Sales Volume (K DDD) by Application (2013-2018)
Table India Biosimilar Drug Sales Volume Market Share by Application (2013-2018)
Figure India Biosimilar Drug Sales Volume Market Share by Application in 2017
Table Amgen Basic Information List
Table Amgen Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2013-2018)
Figure Amgen Biosimilar Drug Sales Growth Rate (2013-2018)
Figure Amgen Biosimilar Drug Sales Global Market Share (2013-2018)
Figure Amgen Biosimilar Drug Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2013-2018)
Figure Eli Lilly Biosimilar Drug Sales Growth Rate (2013-2018)
Figure Eli Lilly Biosimilar Drug Sales Global Market Share (2013-2018)
Figure Eli Lilly Biosimilar Drug Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2013-2018)
Figure Novartis Biosimilar Drug Sales Growth Rate (2013-2018)
Figure Novartis Biosimilar Drug Sales Global Market Share (2013-2018
Figure Novartis Biosimilar Drug Revenue Global Market Share (2013-2018)
Table CP Guojian Pharma Basic Information List
Table CP Guojian Pharma Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Sales Growth Rate (2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Sales Global Market Share (2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Revenue Global Market Share (2013-2018)
Table Biotech Pharma Basic Information List
Table Biotech Pharma Biosimilar Drug Sales (K DDD), Revenue (Million USD), Price (USD/DDD) and Gross Margin (2013-2018)
Figure Biotech Pharma Biosimilar Drug Sales Growth Rate (2013-2018)
Figure Biotech Pharma Biosimilar Drug Sales Global Market Share (2013-2018)
Figure Biotech Pharma Biosimilar Drug Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Players in 2017
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure Global Biosimilar Drug Sales Volume (K DDD) and Growth Rate Forecast (2018-2025)
Figure Global Biosimilar Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Biosimilar Drug Price (USD/DDD) and Trend Forecast (2018-2025)
Table Global Biosimilar Drug Sales Volume (K DDD) Forecast by Regions (2018-2025)
Figure Global Biosimilar Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Biosimilar Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Biosimilar Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Biosimilar Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Biosimilar Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Biosimilar Drug Sales Volume (K DDD) and Growth Rate Forecast (2018-2025)
Figure United States Biosimilar Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Biosimilar Drug Sales Volume (K DDD) and Growth Rate Forecast (2018-2025)
Figure Europe Biosimilar Drug Revenue and Growth Rate Forecast (2018-2025)
Figure China Biosimilar Drug Sales Volume (K DDD) and Growth Rate Forecast (2018-2025)
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Biosimilar Drug Sales Volume (K DDD) and Growth Rate Forecast (2018-2025)
Figure Japan Biosimilar Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biosimilar Drug Sales Volume (K DDD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biosimilar Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Biosimilar Drug Sales Volume (K DDD) and Growth Rate Forecast (2018-2025)
Figure India Biosimilar Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Biosimilar Drug Sales (K DDD) Forecast by Type (2018-2025)
Figure Global Biosimilar Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Biosimilar Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Biosimilar Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Biosimilar Drug Price (USD/DDD) Forecast by Type (2018-2025)
Table Global Biosimilar Drug Sales (K DDD) Forecast by Application (2018-2025)
Figure Global Biosimilar Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

バイオシミラー薬品、注射液、錠剤、強直性脊椎炎、腫瘍、関節リウマチ、循環器系疾患

★調査レポート[バイオシミラー薬品の世界市場:販売動向2018] (コード:QYR80702440)販売に関する免責事項を必ずご確認ください。
★調査レポート[バイオシミラー薬品の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆